Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 8, 97 (2002)
doi:10.1038/nm0202-97b
Pharmacogenomics research to improve transplants
Myrna E. Watanabe1
- Patterson, New York
In an effort to improve the outcome for organ transplant patients, New York University's School of Medicine has embarked on a pharmacogenomics study with a small, Florida-based company to exploit pharmacogenomic data. NYU's Mary Lea Johnson Richards Organ Transplantation Center will provide samples from several hundred patients—responders and nonresponders to immunosuppressive drugs—to DNAPrint genomics, to identify the polymorphisms associated with better drug responses.
To read this story in full you will need to login or make a payment (see right).
